Revolutionize Your Core Lab’s Impact with Unprecedented Sensitivity

The Potential for Disease Detection

A Growing Menu of Advanced Biomarkers

This increased demand and heightened expectations on diagnostics makes high-sensitivity immunoassay testing central to meeting the ever-changing needs of care delivery.
Discover diagnostic techniques and technologies designed to detect and measure very low concentrations of biomolecules with high accuracy and precision.

Sensitivity Detection Limits

Sensitivity Detection Limits

Figure 1. Proven sensitivity of the DxI 9000 Immunoassay Analyzer



 

“At Beckman Coulter, we are committed to making rapid, accurate diagnostics more readily available to healthcare systems worldwide by developing new biomarkers in areas with significant unmet needs like Alzheimer’s disease.”
Kevin O’Reilly
President, Beckman Coulter

 

Bringing Unparalleled Sensitivity to the Core Lab

We are revolutionizing the next generation in specialized diagnostics through high-sensitivity immunoassays, driving innovation, advancing
medical insights, and enhancing diagnostic availability and adaptability to better serve patients across a variety of disease areas.

Proven Diagnostic Sensitivity Across Disease Areas

Beckman Coulter and our proven high-sensitivity immunoassay capabilities found on the DxI 9000 Immunoassay Analyzer* are empowering labs and healthcare teams to address emerging diagnostic challenges across diverse areas, from cardiac to infectious diseases.

Cardiovascular Disease

A complete cardiac diagnostics menu to assess patients at risk for developing or experiencing cardiovascular disease.

 

Learn more ›

Infectious Disease

Our infectious disease assays boost confidence in accurate reporting and timely disease management.

 

Learn more ›

Women’s
Health

From fertility to menopause, highly-sensitive immunoassay testing for all stages of women’s health.

 

Learn more ›

*DxI 9000 Access Immunoassay Analyzer

Lumigen and the Lumigen product marks mentioned herein are trademarks or registered trademarks of Lumigen, Inc. in the United States and other countries. Lumigen is a Beckman Coulter company.